Cytokinetics (CYTK) Other financing activities (2016 - 2025)
Historic Other financing activities for Cytokinetics (CYTK) over the last 13 years, with Q1 2024 value amounting to $18.4 million.
- Cytokinetics' Other financing activities rose 7542.07% to $18.4 million in Q1 2024 from the same period last year, while for Mar 2024 it was $38.6 million, marking a year-over-year increase of 5698.47%. This contributed to the annual value of $19.6 million for FY2024, which is 8665.97% up from last year.
- Per Cytokinetics' latest filing, its Other financing activities stood at $18.4 million for Q1 2024, which was up 7542.07% from $10.5 million recorded in Q1 2023.
- Cytokinetics' Other financing activities' 5-year high stood at $18.4 million during Q1 2024, with a 5-year trough of $2.3 million in Q1 2020.
- Its 5-year average for Other financing activities is $9.1 million, with a median of $9.6 million in 2022.
- Its Other financing activities has fluctuated over the past 5 years, first surged by 20806.01% in 2020, then soared by 952.93% in 2023.
- Quarter analysis of 5 years shows Cytokinetics' Other financing activities stood at $2.3 million in 2020, then surged by 97.29% to $4.4 million in 2021, then soared by 115.82% to $9.6 million in 2022, then grew by 9.53% to $10.5 million in 2023, then surged by 75.42% to $18.4 million in 2024.
- Its last three reported values are $18.4 million in Q1 2024, $10.5 million for Q1 2023, and $9.6 million during Q1 2022.